A study analysing cost-effectiveness and health benefits of drug therapies for treatment of Ulcerative Colitis
Latest Information Update: 24 Nov 2020
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary) ; Golimumab (Primary) ; Infliximab (Primary) ; Tofacitinib (Primary) ; Vedolizumab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 24 Nov 2020 New trial record
- 19 Nov 2020 Results presented at the 23rd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research